Kyverna Therapeutics, Inc.KYTXNASDAQ
Loading
Year-over-year SG&A expense growth
Latest
-3.77%
↓ 100% vs avg
Percentile
P36
Within normal range
Streak
1 qtr
Consecutive growthRecovering
Average
8806.28%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | -3.77% |
| Q2 2025 | -13.84% |
| Q1 2025 | 31.98% |
| Q4 2024 | -4.05% |
| Q3 2024 | 28.84% |
| Q2 2024 | 105641.96% |
| Q1 2024 | -99.86% |
| Q4 2023 | 59.74% |
| Q3 2023 | -8.94% |
| Q2 2023 | 5.96% |
| Q1 2023 | 37.39% |
| Q4 2022 | 0.00% |